Skip to main content

CLRA 6175 Biostatistics: Welcome & Course Readings

Welcome to your course guide

Please find your required library readings below. If you have problems with the links below, please contact the Library. If you have APA questions about these materials, please contact the Writing Center.

CLRA 6175 Required Course Readings

The links are for required readings found in the Walden databases ONLY. For all other readings, see your course resources.

Enter your myWalden user name and password at the prompt.

Anderson, M. M. and Arvidson, C. (2017), Childhood vaccine status and correlation with common nonvaccine-preventable illnesses. Journal of the American Association of Nurse Practitioners, 29: 415–423. doi:10.1002/2327-6924.12464

Buse, J. B., Gumbiner, B., Mathias, N. P., Nelson, D. M., Faja, B. W., Whitcomb, R. W., et al. (1998). Troglitazone use in insulin-treated type 2 diabetic patients. Diabetes Care, 21(9), 1455–1461.

Cohen, J. S. (2006). Risks of troglitazone apparent before approval in USA. Diabetologia, 49(6), 1454–1455.

Curley, M. A., Hibberd, P. L., Fineman, L. D., Wypij, D., Shih, M. C., Thompson, J. E., et al. (2005). Effect of prone positioning on clinical outcomes in children with acute lung injury: A randomized controlled trial. JAMA, 294(2), 229–237.

Gale, E. A. (2006). Troglitazone: The lesson that nobody learned? Diabetologia, 49(1), 1–6.

Halpern, S. D., Karlawish, J. H. T., & Berlin, J. A. (2002). The continuing unethical conduct of underpowered clinical trials. JAMA, 288(3), 358.

Leary, W. E. (1997, January 31). New diabetes drug gets FDA approval: Will reduce or end need for insulin shots. Intelligencer Journal, p. A–1.

Lin, L., Kuo, H., Lai, L., Lin, J., Tseng, C., & Hwang, J. (2008). Inverse correlation between heart rate recovery and metabolic risks in healthy children and adolescents: Insight from the National Health and Nutrition Examination Survey 1999–2002. Diabetes Care, 31(5), 1015–1020.

Pedersen, T. R., Faergeman, O., Kastelein, J. J., Olsson, A. G., Tikkanen, M. J., Holme, I., et al. (2005). High-dose atorvastatin vs. usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL study: A randomized controlled trial. JAMA, 294(19), 2437–2445.

Shekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M.J., et al. (2003). Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: A meta-analysis. JAMA, 289(12), 1537–1545.

Singh, N. N., & Oswald, D. P. (2004). Evidence-based practice. Part I: General methodology. Journal of Child and Family Studies, 13(2), 129–142.

Zodpey, S. (2004). Sample size and power analysis in medical research. Indian Journal of Dermatology, Venereology & Leprology, 70(2), 123–128.

Other Readings

Optional or supplemental readings may or may not be available in the library. Find further information about optional readings here.

If you have questions about your required course textbooks, please contact Customer Care at support@waldenu.edu